* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Pharmacopeia

Pharmacopeia Continues Decline

istockanalyst.com
Oct 3, 2008
        

View SEC Filings View Insider Trading View Annual Reports Pharmacopeia, Inc. (NDAQ: PCOP) shares continued their decline today after the company received a delisting notice from the Nasdaq Stock Market. The company actually...

add comment

IVT's 5th Annual Method Validation Conference

ivtconferences.com
Oct 3, 2008 2 related
        

October 14-16, 2008 at the Hyatt Fisherman's Wharf in San Francisco, CA. This 3-day course is designed for those who manage and execute analytical, bioanlytical and test method validation in the FDA-regulated industry....

add comment

Pharmacopeia Receives Notification From NASDAQ

primenewswire.com
Oct 3, 2008 1 related
        

PRINCETON, N.J., Oct. 3, 2008 (GLOBE NEWSWIRE) -- Pharmacopeia (Nasdaq:PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced it received a notice on September 30, 2008 from...

add comment
                   

Movers: GE, Nike, Discover Financial Services, Goodyear

businessweek.com
Sep 25, 2008 3 related
        

General Electric cuts $0.50-$0.54 third quarter EPS guidance to $0.43-$0.48, reflecting "unprecedented" weakness and volatility in financial services markets. Nike posts better-than-expected $1.03, vs. $1.12 a year ago,...

add comment

Ligand To Buy Pharmacopeia For $70M In Stock-For-Stock Deal With Contingent Payment

tmcnet.com
Sep 25, 2008 1 related
        

September 25, 2008 (FinancialWire) -- Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has agreed to acquire biotechnology company Pharmacopeia Inc. (NASDAQ: PCOP) for about $70 million in a stock-for-stock exchange. Ligand said...

add comment
                   

Regulator says hospitals need strict heparin rules

wtop.com
Sep 24, 2008 10 related
        

By LINDSEY TANNER AP Medical Writer CHICAGO (AP) - A regulatory group told hospitals Wednesday to adopt strict measures to prevent errors involving blood thinners including heparin _ mistakes that have been made nearly...

add comment
                   

Pharmacopeia and GSK alliance identifies new drug compound

pharmaceutical-business-review.com
Sep 18, 2008
        

Pharmacopeia, which discovers and develops small molecule therapeutics, has identified a new lead for advancement in its alliance with GlaxoSmithKline, through its collaboration with the Center of Excellence for External...

add comment
                   

Beware of drug names that look, sound alike

msn.com
Sep 1, 2008 20 related
        

Celebrex or Celexa? Mixing up drug names because they look or sound alike — like this trio — is among the most common types of medical mistakes, and it can be deadly. Now new efforts are aiming to stem the confusion, and...

add comment

Toxic metals found in Ayurvedic meds sold online

reutershealth.com
Aug 26, 2008 21 related
        

NEW YORK (Reuters Health) -Traditional Ayurvedic medicines manufactured in the United States and India and sold via the Internet may contain unacceptable levels of lead, mercury or arsenic, researchers warn in a report...

add comment

USP Opens Site in Brazil

pharmtech.com
Aug 21, 2008
        

São Paulo, Brazil (Aug. 18)—The US Pharmacopeial Convention (USP) added to its international sites with the official opening of its 1800-m2 facility in São Paulo, Brazil. The office and laboratory space will provide local...

add comment
1 2 3 4 5 next »